TW202140584A - Monomer composition for contact lens and polymer for contact lens - Google Patents
Monomer composition for contact lens and polymer for contact lens Download PDFInfo
- Publication number
- TW202140584A TW202140584A TW110109153A TW110109153A TW202140584A TW 202140584 A TW202140584 A TW 202140584A TW 110109153 A TW110109153 A TW 110109153A TW 110109153 A TW110109153 A TW 110109153A TW 202140584 A TW202140584 A TW 202140584A
- Authority
- TW
- Taiwan
- Prior art keywords
- component
- mass
- pollen
- contact lenses
- contact lens
- Prior art date
Links
- 239000000178 monomer Substances 0.000 title claims abstract description 90
- 239000000203 mixture Substances 0.000 title claims abstract description 74
- 229920000642 polymer Polymers 0.000 title claims description 32
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 claims abstract description 22
- -1 hydroxypropyl Chemical group 0.000 claims abstract description 22
- VUIWJRYTWUGOOF-UHFFFAOYSA-N 2-ethenoxyethanol Chemical compound OCCOC=C VUIWJRYTWUGOOF-UHFFFAOYSA-N 0.000 claims abstract description 6
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 claims abstract description 6
- 239000003999 initiator Substances 0.000 claims abstract description 6
- SBVKVAIECGDBTC-UHFFFAOYSA-N 4-hydroxy-2-methylidenebutanamide Chemical compound NC(=O)C(=C)CCO SBVKVAIECGDBTC-UHFFFAOYSA-N 0.000 claims abstract description 5
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims abstract description 5
- LVHBHZANLOWSRM-UHFFFAOYSA-N methylenebutanedioic acid Natural products OC(=O)CC(=C)C(O)=O LVHBHZANLOWSRM-UHFFFAOYSA-N 0.000 claims abstract description 5
- NJNWCIAPVGRBHO-UHFFFAOYSA-N 2-hydroxyethyl-dimethyl-[(oxo-$l^{5}-phosphanylidyne)methyl]azanium Chemical group OCC[N+](C)(C)C#P=O NJNWCIAPVGRBHO-UHFFFAOYSA-N 0.000 claims abstract description 3
- 238000001179 sorption measurement Methods 0.000 claims description 59
- 102000004169 proteins and genes Human genes 0.000 claims description 37
- 108090000623 proteins and genes Proteins 0.000 claims description 37
- 230000000379 polymerizing effect Effects 0.000 claims description 7
- HMBNQNDUEFFFNZ-UHFFFAOYSA-N 4-ethenoxybutan-1-ol Chemical compound OCCCCOC=C HMBNQNDUEFFFNZ-UHFFFAOYSA-N 0.000 claims description 5
- CERQOIWHTDAKMF-UHFFFAOYSA-M Methacrylate Chemical compound CC(=C)C([O-])=O CERQOIWHTDAKMF-UHFFFAOYSA-M 0.000 claims description 5
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 5
- 230000000887 hydrating effect Effects 0.000 claims description 4
- 239000000126 substance Substances 0.000 claims description 4
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims 2
- QYKIQEUNHZKYBP-UHFFFAOYSA-N Vinyl ether Chemical compound C=COC=C QYKIQEUNHZKYBP-UHFFFAOYSA-N 0.000 claims 1
- 125000004177 diethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 claims 1
- 125000004469 siloxy group Chemical group [SiH3]O* 0.000 claims 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 abstract description 21
- 239000001301 oxygen Substances 0.000 abstract description 21
- 229910052760 oxygen Inorganic materials 0.000 abstract description 21
- 230000035699 permeability Effects 0.000 abstract description 21
- 208000035285 Allergic Seasonal Rhinitis Diseases 0.000 abstract description 12
- 208000024891 symptom Diseases 0.000 abstract description 10
- WULAHPYSGCVQHM-UHFFFAOYSA-N 2-(2-ethenoxyethoxy)ethanol Chemical compound OCCOCCOC=C WULAHPYSGCVQHM-UHFFFAOYSA-N 0.000 abstract description 6
- GAWIXWVDTYZWAW-UHFFFAOYSA-N C[CH]O Chemical group C[CH]O GAWIXWVDTYZWAW-UHFFFAOYSA-N 0.000 abstract description 3
- 125000005401 siloxanyl group Chemical group 0.000 abstract 2
- JHPBZFOKBAGZBL-UHFFFAOYSA-N (3-hydroxy-2,2,4-trimethylpentyl) 2-methylprop-2-enoate Chemical compound CC(C)C(O)C(C)(C)COC(=O)C(C)=C JHPBZFOKBAGZBL-UHFFFAOYSA-N 0.000 abstract 1
- 206010048908 Seasonal allergy Diseases 0.000 abstract 1
- KDBPJFGPBDDBGC-UHFFFAOYSA-N ethenoxymethanol Chemical compound OCOC=C KDBPJFGPBDDBGC-UHFFFAOYSA-N 0.000 abstract 1
- 239000004615 ingredient Substances 0.000 description 29
- 230000000052 comparative effect Effects 0.000 description 24
- 230000002401 inhibitory effect Effects 0.000 description 20
- 230000005764 inhibitory process Effects 0.000 description 16
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 15
- 238000012360 testing method Methods 0.000 description 15
- VZSRBBMJRBPUNF-UHFFFAOYSA-N 2-(2,3-dihydro-1H-inden-2-ylamino)-N-[3-oxo-3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propyl]pyrimidine-5-carboxamide Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C(=O)NCCC(N1CC2=C(CC1)NN=N2)=O VZSRBBMJRBPUNF-UHFFFAOYSA-N 0.000 description 14
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 14
- 239000002904 solvent Substances 0.000 description 14
- 238000011156 evaluation Methods 0.000 description 12
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 12
- 238000006116 polymerization reaction Methods 0.000 description 11
- 238000000034 method Methods 0.000 description 9
- 230000000694 effects Effects 0.000 description 8
- WOBHKFSMXKNTIM-UHFFFAOYSA-N Hydroxyethyl methacrylate Chemical compound CC(=C)C(=O)OCCO WOBHKFSMXKNTIM-UHFFFAOYSA-N 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 6
- 238000002835 absorbance Methods 0.000 description 6
- 239000003431 cross linking reagent Substances 0.000 description 6
- ZSIAUFGUXNUGDI-UHFFFAOYSA-N hexan-1-ol Chemical compound CCCCCCO ZSIAUFGUXNUGDI-UHFFFAOYSA-N 0.000 description 6
- 125000005373 siloxane group Chemical group [SiH2](O*)* 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- 238000005406 washing Methods 0.000 description 6
- HWSSEYVMGDIFMH-UHFFFAOYSA-N 2-[2-[2-(2-methylprop-2-enoyloxy)ethoxy]ethoxy]ethyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCCOCCOCCOC(=O)C(C)=C HWSSEYVMGDIFMH-UHFFFAOYSA-N 0.000 description 5
- VVQNEPGJFQJSBK-UHFFFAOYSA-N Methyl methacrylate Chemical compound COC(=O)C(C)=C VVQNEPGJFQJSBK-UHFFFAOYSA-N 0.000 description 5
- AFCARXCZXQIEQB-UHFFFAOYSA-N N-[3-oxo-3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(CCNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 AFCARXCZXQIEQB-UHFFFAOYSA-N 0.000 description 5
- 150000001875 compounds Chemical class 0.000 description 5
- 210000004087 cornea Anatomy 0.000 description 5
- 239000002504 physiological saline solution Substances 0.000 description 5
- KBPLFHHGFOOTCA-UHFFFAOYSA-N 1-Octanol Chemical compound CCCCCCCCO KBPLFHHGFOOTCA-UHFFFAOYSA-N 0.000 description 4
- VHSHLMUCYSAUQU-UHFFFAOYSA-N 2-hydroxypropyl methacrylate Chemical compound CC(O)COC(=O)C(C)=C VHSHLMUCYSAUQU-UHFFFAOYSA-N 0.000 description 4
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 description 4
- AMQJEAYHLZJPGS-UHFFFAOYSA-N N-Pentanol Chemical compound CCCCCO AMQJEAYHLZJPGS-UHFFFAOYSA-N 0.000 description 4
- MWKFXSUHUHTGQN-UHFFFAOYSA-N decan-1-ol Chemical compound CCCCCCCCCCO MWKFXSUHUHTGQN-UHFFFAOYSA-N 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- UUORTJUPDJJXST-UHFFFAOYSA-N n-(2-hydroxyethyl)prop-2-enamide Chemical compound OCCNC(=O)C=C UUORTJUPDJJXST-UHFFFAOYSA-N 0.000 description 4
- JYVLIDXNZAXMDK-UHFFFAOYSA-N pentan-2-ol Chemical compound CCCC(C)O JYVLIDXNZAXMDK-UHFFFAOYSA-N 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- HGCMSCWGVAYWHR-UHFFFAOYSA-N 1,3,5-trimethyl-2-[[phenyl-[(2,4,6-trimethylphenyl)methyl]phosphoryl]methyl]benzene Chemical compound CC1=CC(C)=CC(C)=C1CP(=O)(C=1C=CC=CC=1)CC1=C(C)C=C(C)C=C1C HGCMSCWGVAYWHR-UHFFFAOYSA-N 0.000 description 3
- OMIGHNLMNHATMP-UHFFFAOYSA-N 2-hydroxyethyl prop-2-enoate Chemical compound OCCOC(=O)C=C OMIGHNLMNHATMP-UHFFFAOYSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 3
- 102100026735 Coagulation factor VIII Human genes 0.000 description 3
- 241000218692 Cryptomeria Species 0.000 description 3
- 101000911390 Homo sapiens Coagulation factor VIII Proteins 0.000 description 3
- MKYBYDHXWVHEJW-UHFFFAOYSA-N N-[1-oxo-1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propan-2-yl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(C(C)NC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 MKYBYDHXWVHEJW-UHFFFAOYSA-N 0.000 description 3
- NIPNSKYNPDTRPC-UHFFFAOYSA-N N-[2-oxo-2-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(CNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 NIPNSKYNPDTRPC-UHFFFAOYSA-N 0.000 description 3
- 241000702295 Tomato golden mosaic virus Species 0.000 description 3
- JAWMENYCRQKKJY-UHFFFAOYSA-N [3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-ylmethyl)-1-oxa-2,8-diazaspiro[4.5]dec-2-en-8-yl]-[2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidin-5-yl]methanone Chemical compound N1N=NC=2CN(CCC=21)CC1=NOC2(C1)CCN(CC2)C(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F JAWMENYCRQKKJY-UHFFFAOYSA-N 0.000 description 3
- SXEHKFHPFVVDIR-UHFFFAOYSA-N [4-(4-hydrazinylphenyl)phenyl]hydrazine Chemical compound C1=CC(NN)=CC=C1C1=CC=C(NN)C=C1 SXEHKFHPFVVDIR-UHFFFAOYSA-N 0.000 description 3
- 239000005456 alcohol based solvent Substances 0.000 description 3
- 239000012298 atmosphere Substances 0.000 description 3
- BTANRVKWQNVYAZ-UHFFFAOYSA-N butan-2-ol Chemical compound CCC(C)O BTANRVKWQNVYAZ-UHFFFAOYSA-N 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 238000005886 esterification reaction Methods 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- CYIGRWUIQAVBFG-UHFFFAOYSA-N 1,2-bis(2-ethenoxyethoxy)ethane Chemical compound C=COCCOCCOCCOC=C CYIGRWUIQAVBFG-UHFFFAOYSA-N 0.000 description 2
- 239000005968 1-Decanol Substances 0.000 description 2
- LESMLVDJJCWZAJ-UHFFFAOYSA-N 2-(diphenylphosphorylmethyl)-1,3,5-trimethylbenzene Chemical compound CC1=CC(C)=CC(C)=C1CP(=O)(C=1C=CC=CC=1)C1=CC=CC=C1 LESMLVDJJCWZAJ-UHFFFAOYSA-N 0.000 description 2
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 2
- XFCMNSHQOZQILR-UHFFFAOYSA-N 2-[2-(2-methylprop-2-enoyloxy)ethoxy]ethyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCCOCCOC(=O)C(C)=C XFCMNSHQOZQILR-UHFFFAOYSA-N 0.000 description 2
- LTHJXDSHSVNJKG-UHFFFAOYSA-N 2-[2-[2-[2-(2-methylprop-2-enoyloxy)ethoxy]ethoxy]ethoxy]ethyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCCOCCOCCOCCOC(=O)C(C)=C LTHJXDSHSVNJKG-UHFFFAOYSA-N 0.000 description 2
- IEVADDDOVGMCSI-UHFFFAOYSA-N 2-hydroxybutyl 2-methylprop-2-enoate Chemical compound CCC(O)COC(=O)C(C)=C IEVADDDOVGMCSI-UHFFFAOYSA-N 0.000 description 2
- YLZOPXRUQYQQID-UHFFFAOYSA-N 3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)-1-[4-[2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidin-5-yl]piperazin-1-yl]propan-1-one Chemical compound N1N=NC=2CN(CCC=21)CCC(=O)N1CCN(CC1)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F YLZOPXRUQYQQID-UHFFFAOYSA-N 0.000 description 2
- BBNUYEDGTKFYIM-UHFFFAOYSA-N 3-iodopropyl-tris(trimethylsilyloxy)silane Chemical compound C[Si](C)(C)O[Si](O[Si](C)(C)C)(O[Si](C)(C)C)CCCI BBNUYEDGTKFYIM-UHFFFAOYSA-N 0.000 description 2
- YKXAYLPDMSGWEV-UHFFFAOYSA-N 4-hydroxybutyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCCCCO YKXAYLPDMSGWEV-UHFFFAOYSA-N 0.000 description 2
- NDWUBGAGUCISDV-UHFFFAOYSA-N 4-hydroxybutyl prop-2-enoate Chemical compound OCCCCOC(=O)C=C NDWUBGAGUCISDV-UHFFFAOYSA-N 0.000 description 2
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 235000004385 Conyza canadensis Nutrition 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 2
- 235000007239 Heracleum sphondylium Nutrition 0.000 description 2
- 244000045393 Heracleum sphondylium Species 0.000 description 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 2
- FHKPLLOSJHHKNU-INIZCTEOSA-N [(3S)-3-[8-(1-ethyl-5-methylpyrazol-4-yl)-9-methylpurin-6-yl]oxypyrrolidin-1-yl]-(oxan-4-yl)methanone Chemical compound C(C)N1N=CC(=C1C)C=1N(C2=NC=NC(=C2N=1)O[C@@H]1CN(CC1)C(=O)C1CCOCC1)C FHKPLLOSJHHKNU-INIZCTEOSA-N 0.000 description 2
- 230000000172 allergic effect Effects 0.000 description 2
- 125000003368 amide group Chemical group 0.000 description 2
- 208000010668 atopic eczema Diseases 0.000 description 2
- 239000006227 byproduct Substances 0.000 description 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 2
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 2
- LQZZUXJYWNFBMV-UHFFFAOYSA-N dodecan-1-ol Chemical compound CCCCCCCCCCCCO LQZZUXJYWNFBMV-UHFFFAOYSA-N 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 125000004185 ester group Chemical group 0.000 description 2
- ALCMFIRBTSSHJM-UHFFFAOYSA-N ethane-1,2-diol;2-methylidenebutanedioic acid Chemical compound OCCO.OC(=O)CC(=C)C(O)=O ALCMFIRBTSSHJM-UHFFFAOYSA-N 0.000 description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 2
- 239000003889 eye drop Substances 0.000 description 2
- 229940012356 eye drops Drugs 0.000 description 2
- 239000011261 inert gas Substances 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 238000000053 physical method Methods 0.000 description 2
- 238000009281 ultraviolet germicidal irradiation Methods 0.000 description 2
- 229920002818 (Hydroxyethyl)methacrylate Polymers 0.000 description 1
- ZXHDVRATSGZISC-UHFFFAOYSA-N 1,2-bis(ethenoxy)ethane Chemical compound C=COCCOC=C ZXHDVRATSGZISC-UHFFFAOYSA-N 0.000 description 1
- VNQXSTWCDUXYEZ-UHFFFAOYSA-N 1,7,7-trimethylbicyclo[2.2.1]heptane-2,3-dione Chemical compound C1CC2(C)C(=O)C(=O)C1C2(C)C VNQXSTWCDUXYEZ-UHFFFAOYSA-N 0.000 description 1
- SAMJGBVVQUEMGC-UHFFFAOYSA-N 1-ethenoxy-2-(2-ethenoxyethoxy)ethane Chemical compound C=COCCOCCOC=C SAMJGBVVQUEMGC-UHFFFAOYSA-N 0.000 description 1
- JWYVGKFDLWWQJX-UHFFFAOYSA-N 1-ethenylazepan-2-one Chemical compound C=CN1CCCCCC1=O JWYVGKFDLWWQJX-UHFFFAOYSA-N 0.000 description 1
- PBGPBHYPCGDFEZ-UHFFFAOYSA-N 1-ethenylpiperidin-2-one Chemical compound C=CN1CCCCC1=O PBGPBHYPCGDFEZ-UHFFFAOYSA-N 0.000 description 1
- 239000012956 1-hydroxycyclohexylphenyl-ketone Substances 0.000 description 1
- MGMSZKIPUNOMCS-UHFFFAOYSA-N 2-(2-ethenoxyethoxy)ethyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCCOCCOC=C MGMSZKIPUNOMCS-UHFFFAOYSA-N 0.000 description 1
- URQQDYIVGXOEDA-UHFFFAOYSA-N 2-(2-ethenoxyethoxy)ethyl prop-2-enoate Chemical compound C=COCCOCCOC(=O)C=C URQQDYIVGXOEDA-UHFFFAOYSA-N 0.000 description 1
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 1
- LBNDGEZENJUBCO-UHFFFAOYSA-N 2-[2-(2-methylprop-2-enoyloxy)ethyl]butanedioic acid Chemical compound CC(=C)C(=O)OCCC(C(O)=O)CC(O)=O LBNDGEZENJUBCO-UHFFFAOYSA-N 0.000 description 1
- UTOONOCRMYRNMO-UHFFFAOYSA-N 2-[2-[2-(2-ethenoxyethoxy)ethoxy]ethoxy]ethanol Chemical compound OCCOCCOCCOCCOC=C UTOONOCRMYRNMO-UHFFFAOYSA-N 0.000 description 1
- SAFFSEYSJOXUCD-UHFFFAOYSA-N 2-[[(2,6-dimethoxyphenyl)methyl-(2,4,4-trimethylpentyl)phosphoryl]methyl]-1,3-dimethoxybenzene Chemical compound COC1=CC=CC(OC)=C1CP(=O)(CC(C)CC(C)(C)C)CC1=C(OC)C=CC=C1OC SAFFSEYSJOXUCD-UHFFFAOYSA-N 0.000 description 1
- XMLYCEVDHLAQEL-UHFFFAOYSA-N 2-hydroxy-2-methyl-1-phenylpropan-1-one Chemical compound CC(C)(O)C(=O)C1=CC=CC=C1 XMLYCEVDHLAQEL-UHFFFAOYSA-N 0.000 description 1
- NJRHMGPRPPEGQL-UHFFFAOYSA-N 2-hydroxybutyl prop-2-enoate Chemical compound CCC(O)COC(=O)C=C NJRHMGPRPPEGQL-UHFFFAOYSA-N 0.000 description 1
- GWZMWHWAWHPNHN-UHFFFAOYSA-N 2-hydroxypropyl prop-2-enoate Chemical compound CC(O)COC(=O)C=C GWZMWHWAWHPNHN-UHFFFAOYSA-N 0.000 description 1
- BQZJOQXSCSZQPS-UHFFFAOYSA-N 2-methoxy-1,2-diphenylethanone Chemical compound C=1C=CC=CC=1C(OC)C(=O)C1=CC=CC=C1 BQZJOQXSCSZQPS-UHFFFAOYSA-N 0.000 description 1
- SEILKFZTLVMHRR-UHFFFAOYSA-N 2-phosphonooxyethyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCCOP(O)(O)=O SEILKFZTLVMHRR-UHFFFAOYSA-N 0.000 description 1
- GNSFRPWPOGYVLO-UHFFFAOYSA-N 3-hydroxypropyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCCCO GNSFRPWPOGYVLO-UHFFFAOYSA-N 0.000 description 1
- DBCAQXHNJOFNGC-UHFFFAOYSA-N 4-bromo-1,1,1-trifluorobutane Chemical compound FC(F)(F)CCCBr DBCAQXHNJOFNGC-UHFFFAOYSA-N 0.000 description 1
- DEXFNLNNUZKHNO-UHFFFAOYSA-N 6-[3-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperidin-1-yl]-3-oxopropyl]-3H-1,3-benzoxazol-2-one Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C1CCN(CC1)C(CCC1=CC2=C(NC(O2)=O)C=C1)=O DEXFNLNNUZKHNO-UHFFFAOYSA-N 0.000 description 1
- 235000009051 Ambrosia paniculata var. peruviana Nutrition 0.000 description 1
- 235000003097 Artemisia absinthium Nutrition 0.000 description 1
- 240000001851 Artemisia dracunculus Species 0.000 description 1
- 235000017731 Artemisia dracunculus ssp. dracunculus Nutrition 0.000 description 1
- 235000003261 Artemisia vulgaris Nutrition 0.000 description 1
- 240000004183 Bongardia chrysogonum Species 0.000 description 1
- OXJGJKIURHREKH-UHFFFAOYSA-O CC(=C)C(=O)OCCP(=O)=C(O)C[N+](C)(C)C Chemical compound CC(=C)C(=O)OCCP(=O)=C(O)C[N+](C)(C)C OXJGJKIURHREKH-UHFFFAOYSA-O 0.000 description 1
- 241000218645 Cedrus Species 0.000 description 1
- 241000218691 Cupressaceae Species 0.000 description 1
- 235000011201 Ginkgo Nutrition 0.000 description 1
- 244000194101 Ginkgo biloba Species 0.000 description 1
- 235000008100 Ginkgo biloba Nutrition 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 102000003992 Peroxidases Human genes 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 208000036071 Rhinorrhea Diseases 0.000 description 1
- 206010039101 Rhinorrhoea Diseases 0.000 description 1
- 235000000914 Solidago virgaurea Nutrition 0.000 description 1
- 206010041349 Somnolence Diseases 0.000 description 1
- DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000001252 acrylic acid derivatives Chemical class 0.000 description 1
- 125000003647 acryloyl group Chemical group O=C([*])C([H])=C([H])[H] 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- 239000000043 antiallergic agent Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 229910052786 argon Inorganic materials 0.000 description 1
- 239000001138 artemisia absinthium Substances 0.000 description 1
- 239000000607 artificial tear Substances 0.000 description 1
- MQDJYUACMFCOFT-UHFFFAOYSA-N bis[2-(1-hydroxycyclohexyl)phenyl]methanone Chemical compound C=1C=CC=C(C(=O)C=2C(=CC=CC=2)C2(O)CCCCC2)C=1C1(O)CCCCC1 MQDJYUACMFCOFT-UHFFFAOYSA-N 0.000 description 1
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 1
- 239000004327 boric acid Substances 0.000 description 1
- 229930006711 bornane-2,3-dione Natural products 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 150000005690 diesters Chemical class 0.000 description 1
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 230000005183 environmental health Effects 0.000 description 1
- 230000032050 esterification Effects 0.000 description 1
- GKEMUBZAKCZMKO-UHFFFAOYSA-N ethane-1,2-diol;ethene Chemical group C=C.OCCO GKEMUBZAKCZMKO-UHFFFAOYSA-N 0.000 description 1
- STVZJERGLQHEKB-UHFFFAOYSA-N ethylene glycol dimethacrylate Substances CC(=C)C(=O)OCCOC(=O)C(C)=C STVZJERGLQHEKB-UHFFFAOYSA-N 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 230000001678 irradiating effect Effects 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 230000005923 long-lasting effect Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 125000005641 methacryl group Chemical group 0.000 description 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 1
- 235000019796 monopotassium phosphate Nutrition 0.000 description 1
- ZIUHHBKFKCYYJD-UHFFFAOYSA-N n,n'-methylenebisacrylamide Chemical compound C=CC(=O)NCNC(=O)C=C ZIUHHBKFKCYYJD-UHFFFAOYSA-N 0.000 description 1
- OVHHHVAVHBHXAK-UHFFFAOYSA-N n,n-diethylprop-2-enamide Chemical compound CCN(CC)C(=O)C=C OVHHHVAVHBHXAK-UHFFFAOYSA-N 0.000 description 1
- 229940088644 n,n-dimethylacrylamide Drugs 0.000 description 1
- YLGYACDQVQQZSW-UHFFFAOYSA-N n,n-dimethylprop-2-enamide Chemical compound CN(C)C(=O)C=C YLGYACDQVQQZSW-UHFFFAOYSA-N 0.000 description 1
- PNLUGRYDUHRLOF-UHFFFAOYSA-N n-ethenyl-n-methylacetamide Chemical compound C=CN(C)C(C)=O PNLUGRYDUHRLOF-UHFFFAOYSA-N 0.000 description 1
- RQAKESSLMFZVMC-UHFFFAOYSA-N n-ethenylacetamide Chemical compound CC(=O)NC=C RQAKESSLMFZVMC-UHFFFAOYSA-N 0.000 description 1
- ZQXSMRAEXCEDJD-UHFFFAOYSA-N n-ethenylformamide Chemical compound C=CNC=O ZQXSMRAEXCEDJD-UHFFFAOYSA-N 0.000 description 1
- QNILTEGFHQSKFF-UHFFFAOYSA-N n-propan-2-ylprop-2-enamide Chemical compound CC(C)NC(=O)C=C QNILTEGFHQSKFF-UHFFFAOYSA-N 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- FZUGPQWGEGAKET-UHFFFAOYSA-N parbenate Chemical compound CCOC(=O)C1=CC=C(N(C)C)C=C1 FZUGPQWGEGAKET-UHFFFAOYSA-N 0.000 description 1
- 108040007629 peroxidase activity proteins Proteins 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 239000008055 phosphate buffer solution Substances 0.000 description 1
- YHHSONZFOIEMCP-UHFFFAOYSA-O phosphocholine Chemical compound C[N+](C)(C)CCOP(O)(O)=O YHHSONZFOIEMCP-UHFFFAOYSA-O 0.000 description 1
- 125000002525 phosphocholine group Chemical group OP(=O)(OCC[N+](C)(C)C)O* 0.000 description 1
- PJNZPQUBCPKICU-UHFFFAOYSA-N phosphoric acid;potassium Chemical compound [K].OP(O)(O)=O PJNZPQUBCPKICU-UHFFFAOYSA-N 0.000 description 1
- 229950004354 phosphorylcholine Drugs 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920000139 polyethylene terephthalate Polymers 0.000 description 1
- 239000005020 polyethylene terephthalate Substances 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- FBCQUCJYYPMKRO-UHFFFAOYSA-N prop-2-enyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCC=C FBCQUCJYYPMKRO-UHFFFAOYSA-N 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 239000013049 sediment Substances 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 125000006850 spacer group Chemical group 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 125000001302 tertiary amino group Chemical group 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- 238000011179 visual inspection Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F22/00—Homopolymers and copolymers of compounds having one or more unsaturated aliphatic radicals each having only one carbon-to-carbon double bond, and at least one being terminated by a carboxyl radical and containing at least one other carboxyl radical in the molecule; Salts, anhydrides, esters, amides, imides or nitriles thereof
- C08F22/10—Esters
- C08F22/12—Esters of phenols or saturated alcohols
- C08F22/20—Esters containing oxygen in addition to the carboxy oxygen
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F230/00—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and containing phosphorus, selenium, tellurium or a metal
- C08F230/04—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and containing phosphorus, selenium, tellurium or a metal containing a metal
- C08F230/08—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and containing phosphorus, selenium, tellurium or a metal containing a metal containing silicon
-
- G—PHYSICS
- G02—OPTICS
- G02C—SPECTACLES; SUNGLASSES OR GOGGLES INSOFAR AS THEY HAVE THE SAME FEATURES AS SPECTACLES; CONTACT LENSES
- G02C7/00—Optical parts
- G02C7/02—Lenses; Lens systems ; Methods of designing lenses
- G02C7/04—Contact lenses for the eyes
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Polymers & Plastics (AREA)
- Ophthalmology & Optometry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Optics & Photonics (AREA)
- Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
- Eyeglasses (AREA)
Abstract
Description
本發明係關於一種隱形眼鏡用單體組合物、隱形眼鏡用聚合物、及由該聚合物之水合物所構成之隱形眼鏡。The present invention relates to a monomer composition for contact lenses, a polymer for contact lenses, and contact lenses composed of a hydrate of the polymer.
由於軟性隱形眼鏡簡易輕便且方便使用,因此使用者數量激增,日本國內之軟性隱形眼鏡配戴者超過1000萬人,且每天之配戴時間亦較長。又,推測日本國內之花粉症之患病率高達日本國民之1/3(非專利文獻1),認為其人數高達3000萬人。因此,可認為現狀係多數軟性隱形眼鏡配戴者亦併發有花粉症。Since soft contact lenses are simple, portable and convenient to use, the number of users has increased sharply. There are more than 10 million soft contact lens wearers in Japan, and they wear them for a long time each day. In addition, it is estimated that the prevalence of hay fever in Japan is as high as 1/3 of that of Japanese nationals (Non-Patent Document 1), and the number is considered to be as high as 30 million. Therefore, it can be considered that most soft contact lens wearers also have hay fever.
花粉症係由過敏反應所導致,例如自柳杉等飛散出之花粉或自該等花粉釋出之花粉蛋白等附著、吸附於角膜表面或軟性隱形眼鏡表面,從而產生症狀。作為花粉症之代表性症狀,可列舉流鼻涕或流淚等。 為了治療、緩和、預防該等由花粉症所引起之過敏症狀,作為藥學/化學方法,已知有利用調配有抗過敏藥物之醫藥品或滴眼劑來進行治療、緩和(專利文獻1),作為物理方法,已知有配戴眼鏡或眼罩等,自源頭上阻止花粉或花粉蛋白等接觸角膜表面或軟性隱形眼鏡表面(專利文獻2、專利文獻3)等。Hay fever is caused by allergic reactions. For example, pollen scattered from cedar or pollen protein released from such pollen adheres and adsorbs on the surface of the cornea or the surface of soft contact lenses, resulting in symptoms. As a representative symptom of hay fever, a runny nose or watery nose can be cited. In order to treat, alleviate, and prevent the allergic symptoms caused by hay fever, as a pharmaceutical/chemical method, it is known to use medicines or eye drops formulated with anti-allergic drugs for treatment and relief (Patent Document 1). As a physical method, it is known to wear glasses or eye masks to prevent pollen or pollen protein from contacting the surface of the cornea or the surface of soft contact lenses from the source (Patent Document 2 and Patent Document 3).
同時,已知雖然藥學/化學方法展現出較高之有效性,但存在誘發困倦感等副作用,又,關於物理方法,若在花粉或花粉蛋白附著、吸附於角膜表面或軟性隱形眼鏡表面之前則該方法有效,一旦花粉或花粉蛋白附著、吸附於角膜表面或軟性隱形眼鏡表面,就會失去該有效性。進而,亦存在如下擔憂:於軟性隱形眼鏡之配戴過程中,一旦花粉或花粉蛋白產生附著,則難以用淚液或人工淚液等滴眼劑、洗眼劑等沖洗掉,從而導致過敏症狀持續較長時間。又,由於每天之配戴時間較長,因此亦需要向隱形眼鏡賦予較高之透氧性。 因此,要求開發一種技術,能夠藉由抑制花粉或花粉蛋白附著、吸附於軟性隱形眼鏡表面或角膜表面來緩和、減輕花粉症之症狀及不適感,但是針對該等需求之技術開發並不充分,缺少有效之方法。 先前技術文獻 非專利文獻At the same time, it is known that although pharmacological/chemical methods exhibit high effectiveness, they have side effects such as inducing drowsiness. In addition, with regard to physical methods, if pollen or pollen protein adheres to and adsorbs on the surface of the cornea or the surface of soft contact lenses, it is known that This method is effective. Once pollen or pollen protein adheres to and adsorbs on the surface of the cornea or the surface of soft contact lenses, the effectiveness will be lost. Furthermore, there is also the following concern: once pollen or pollen protein adheres during the wearing process of soft contact lenses, it will be difficult to wash away with tears or artificial tears and other eye drops, eye washes, etc., resulting in long-lasting allergic symptoms time. In addition, since the wearing time per day is long, it is also necessary to impart high oxygen permeability to the contact lens. Therefore, it is required to develop a technology that can alleviate and alleviate the symptoms and discomfort of hay fever by inhibiting the adhesion of pollen or pollen protein and adsorbing on the surface of soft contact lenses or the surface of the cornea. However, the technology development for these needs is insufficient. Lack of effective methods. Prior art literature Non-patent literature
非專利文獻1:環境省、花粉症環境保健指南-2014年1月修訂版- 專利文獻Non-Patent Document 1: Ministry of the Environment, Hay fever Environmental Health Guide-Revised Edition in January 2014- Patent literature
專利文獻1:日本專利特開2018-203791號公報 專利文獻2:日本專利特開2017-134100號公報 專利文獻3:日本專利特開2014-111147號公報Patent Document 1: Japanese Patent Laid-Open No. 2018-203791 Patent Document 2: Japanese Patent Laid-Open No. 2017-134100 Patent Document 3: Japanese Patent Laid-Open No. 2014-111147
[發明所欲解決之問題][The problem to be solved by the invention]
本發明之課題在於,提供一種隱形眼鏡用單體組合物,其可形成具有如下特性之隱形眼鏡:能夠藉由抑制花粉及/或花粉蛋白吸附於隱形眼鏡表面來緩和花粉症之症狀,從而改善不適感,且透氧性亦優異。 [解決問題之技術手段]The subject of the present invention is to provide a monomer composition for contact lenses, which can form contact lenses with the following characteristics: can alleviate the symptoms of hay fever by inhibiting the adsorption of pollen and/or pollen protein on the surface of the contact lens, thereby improving Discomfort, and excellent oxygen permeability. [Technical means to solve the problem]
本發明者等人為了解決上述課題而進行了銳意研究。結果發現,藉由使用含有3種親水性單體、2種含矽氧烷基之單體且進而含有光聚合起始劑之隱形眼鏡用單體組合物,能夠形成一種抑制花粉及/或花粉蛋白之吸附且透氧性優異之隱形眼鏡。該隱形眼鏡能夠緩和花粉症之症狀,從而改善不適感。 即,本發明如下所述。The inventors of the present invention conducted intensive research in order to solve the above-mentioned problems. As a result, it was found that by using a monomer composition for contact lenses that contains 3 types of hydrophilic monomers, 2 types of siloxane group-containing monomers, and further contains a photopolymerization initiator, a pollen and/or pollen inhibitor can be formed. A contact lens with protein adsorption and excellent oxygen permeability. The contact lens can alleviate the symptoms of hay fever, thereby improving discomfort. That is, the present invention is as follows.
[1]一種隱形眼鏡用單體組合物,其係含有如下成分之組合物: (A)式(1)所表示之含磷酸膽鹼基之甲基丙烯酸酯單體; (B)選自由(甲基)丙烯酸羥基乙酯、(甲基)丙烯酸羥基丙酯、(甲基)丙烯酸羥基丁酯、羥乙基丙烯醯胺、乙二醇單乙烯醚、四亞甲基二醇單乙烯醚、及二乙二醇單乙烯醚所組成之群中之一種以上之含羥基之單體; (C)式(2)所表示之含矽氧烷基之伊康酸二酯單體; (D)式(3)所表示之含矽氧烷基之(甲基)丙烯酸酯; (E)N-乙烯基吡咯啶酮;以及 (F)光聚合起始劑; 當將上述組合物中之單體成分之合計設為100質量%時,該組合物含有2~40質量%之(A)成分、5~45質量%之(B)成分、7~35質量%之(C)成分、7~55質量%之(D)成分、0.5~35質量%之(E)成分、及0.1~10質量%之(F)成分, [化1] [化2] [化3] (式(3)中,R1 為氫原子或甲基,n為1~15)。 [2]一種隱形眼鏡用聚合物,其係使如上述[1]之隱形眼鏡用單體組合物進行聚合而獲得。 [3]一種隱形眼鏡,其係使如上述[2]之隱形眼鏡用聚合物進行水合而獲得。 [4]如上述[3]之隱形眼鏡,其用於抑制花粉及/或花粉蛋白之吸附。 [發明之效果][1] A monomer composition for contact lenses, which is a composition containing the following components: (A) a phosphocholine group-containing methacrylate monomer represented by formula (1); (B) is selected from ( Hydroxyethyl meth)acrylate, hydroxypropyl (meth)acrylate, hydroxybutyl (meth)acrylate, hydroxyethyl acrylamide, ethylene glycol monovinyl ether, tetramethylene glycol monovinyl ether, And one or more hydroxyl-containing monomers in the group consisting of diethylene glycol monovinyl ether; (C) a siloxyalkyl-containing itaconic acid diester monomer represented by formula (2); (D) The siloxane group-containing (meth)acrylate represented by formula (3); (E) N-vinylpyrrolidone; and (F) photopolymerization initiator; When the monomer in the above composition When the total of the components is 100% by mass, the composition contains 2-40% by mass (A) component, 5-45% by mass (B) component, 7-35% by mass (C) component, and 7-55 Mass% (D) component, 0.5-35% by mass (E) component, and 0.1-10% by mass (F) component, [Chemical 1] [化2] [化3] (In formula (3), R 1 is a hydrogen atom or a methyl group, and n is 1 to 15). [2] A polymer for contact lenses obtained by polymerizing the monomer composition for contact lenses as described in [1] above. [3] A contact lens obtained by hydrating the polymer for contact lenses as described in [2] above. [4] The contact lens of [3] above, which is used to inhibit the adsorption of pollen and/or pollen protein. [Effects of the invention]
藉由使用本發明之隱形眼鏡用單體組合物,可形成一種具有如下特性之隱形眼鏡:能夠抑制花粉之吸附及花粉蛋白之吸附,進而能夠緩和、減輕花粉症之症狀,亦能夠改善不適感。除此之外,本發明之隱形眼鏡用單體組合物可形成透氧性優異之隱形眼鏡。By using the monomer composition for contact lenses of the present invention, a contact lens with the following characteristics can be formed: it can inhibit the adsorption of pollen and the adsorption of pollen protein, thereby alleviating and alleviating the symptoms of hay fever and improving discomfort. . In addition, the monomer composition for contact lenses of the present invention can form contact lenses with excellent oxygen permeability.
[隱形眼鏡用單體組合物] 本發明之隱形眼鏡用單體組合物係含有(A)~(F)成分作為必須成分之組合物,較佳為均勻之透明液體。本發明之隱形眼鏡用聚合物係使該隱形眼鏡用單體組合物聚合而成,本發明之隱形眼鏡係使該隱形眼鏡用聚合物進行水合而獲得。[Monomer composition for contact lenses] The monomer composition for contact lenses of the present invention is a composition containing the components (A) to (F) as essential components, and is preferably a uniform transparent liquid. The polymer for contact lenses of the present invention is obtained by polymerizing the monomer composition for contact lenses, and the contact lens of the present invention is obtained by hydrating the polymer for contact lenses.
本說明書中,當階段性地記載較佳之數值範圍(例如濃度或重量平均分子量之範圍等)時,各下限值及上限值可各自獨立地進行組合。例如,於「較佳為10以上,更佳為20以上,並且較佳為100以下,更佳為90以下」之記載中,可將「較佳之下限值:10」與「更佳之上限值:90」組合成「10以上90以下」。例如,於「較佳為10~100,更佳為20~90」之記載中,亦可同樣地使之成為「10~90」。In this specification, when a preferable numerical range (for example, a range of a concentration or a weight average molecular weight, etc.) is described step by step, each lower limit and upper limit can be combined independently. For example, in the description of "preferably 10 or more, more preferably 20 or more, and preferably 100 or less, and more preferably 90 or less", "preferably lower limit: 10" and "better upper limit" Value: 90" is combined into "10 above 90". For example, in the description of "preferably 10 to 100, more preferably 20 to 90", it may be similarly made to "10 to 90".
於本發明中,「(甲基)丙烯酸」意指丙烯酸或甲基丙烯酸(Methacryl),「(甲基)丙烯醯基」意指丙烯醯基或甲基丙烯醯基(Methacryloyl),「(甲基)丙烯酸酯」意指丙烯酸酯或甲基丙烯酸酯(Methacrylate)。In the present invention, "(meth)acrylic acid" means acrylic acid or methacrylic acid (Methacryl), "(meth)acryloyl group" means acrylic acid group or methacryloyl group (Methacryloyl), "(former "Acrylate" means acrylate or methacrylate.
<(A)成分:含磷酸膽鹼基之甲基丙烯酸酯單體> 本發明中之(A)成分為下述式(1)所表示之含磷酸膽鹼基之甲基丙烯酸酯單體,具體而言,係2-甲基丙烯醯氧乙基磷酸膽鹼(MPC)。藉由含有特定量之(A)成分,能夠向作為本發明之隱形眼鏡用單體組合物之聚合物的隱形眼鏡賦予花粉及花粉蛋白之吸附抑制作用。<Component (A): Methacrylate monomer containing phosphorylcholine> The component (A) in the present invention is a phosphorylcholine group-containing methacrylate monomer represented by the following formula (1), specifically, 2-methacryloxyethyl phosphorylcholine (MPC) ). By containing the component (A) in a specific amount, the contact lens, which is the polymer of the monomer composition for contact lenses of the present invention, can impart the adsorption inhibitory effect of pollen and pollen protein.
[化4] [化4]
於本發明之隱形眼鏡用單體組合物中,當將所有單體成分之合計設為100質量%時,(A)成分之含有比率為2~40質量%。就向隱形眼鏡賦予花粉及花粉蛋白之吸附抑制作用之觀點而言,(A)成分之含有比率較佳為5~40質量%,更佳為10~30質量%,進而較佳為15~30質量%。 若(A)成分之含有比率未達2質量%,則有隱形眼鏡無法獲得充分之花粉及花粉蛋白之吸附抑制作用之風險,若多於40質量%,則有難以使(A)成分溶解於隱形眼鏡用單體組合物中,導致隱形眼鏡自身之機械強度降低,從而難以製作隱形眼鏡之風險。 再者,本說明書中,所謂單體成分,意指具有1個(甲基)丙烯酸酯基、乙烯基等聚合性不飽和基之化合物。因此,所謂單體成分,意指除隱形眼鏡用單體組合物所含之作為必須成分之(A)成分、(B)成分、(C)成分、(D)成分、及(E)成分以外,可作為任意成分而調配之(G)成分。In the monomer composition for contact lenses of the present invention, when the total of all monomer components is 100% by mass, the content ratio of the component (A) is 2-40% by mass. From the viewpoint of imparting pollen and pollen protein adsorption inhibitory effects to contact lenses, the content of component (A) is preferably 5-40% by mass, more preferably 10-30% by mass, and still more preferably 15-30 quality%. If the content of (A) component is less than 2% by mass, there is a risk that the contact lens will not be able to obtain sufficient pollen and pollen protein adsorption inhibitory effect. If it is more than 40% by mass, it may be difficult to dissolve (A) component in In the monomer composition for contact lenses, there is a risk that the mechanical strength of the contact lens itself is reduced, and the production of the contact lens becomes difficult. In addition, in this specification, the term "monomer component" means a compound having a polymerizable unsaturated group such as a (meth)acrylate group and a vinyl group. Therefore, the term "monomer component" means excluding the (A) component, (B) component, (C) component, (D) component, and (E) component as essential components contained in the contact lens monomer composition , Component (G) that can be formulated as an optional component.
<(B)成分:含羥基之單體> 本發明中之(B)成分係選自由(甲基)丙烯酸羥基乙酯、(甲基)丙烯酸羥基丙酯、(甲基)丙烯酸羥基丁酯、羥乙基丙烯醯胺、乙二醇單乙烯醚、四亞甲基二醇單乙烯醚、及二乙二醇單乙烯醚所組成之群中之一種以上之含羥基之單體。藉由含有特定量之(B)成分,使得(A)成分於本發明之隱形眼鏡用單體組合物中之溶解得以改善。<Component (B): Hydroxyl-containing monomer> The component (B) in the present invention is selected from hydroxyethyl (meth)acrylate, hydroxypropyl (meth)acrylate, hydroxybutyl (meth)acrylate, hydroxyethyl acrylamide, ethylene glycol monoethylene One or more hydroxyl-containing monomers in the group consisting of ether, tetramethylene glycol monovinyl ether, and diethylene glycol monovinyl ether. By containing the component (B) in a specific amount, the dissolution of the component (A) in the monomer composition for contact lenses of the present invention is improved.
作為(B)成分之具體例,可列舉丙烯酸2-羥基乙酯、甲基丙烯酸2-羥基乙酯、丙烯酸2-羥基丙酯、甲基丙烯酸2-羥基丙酯、丙烯酸4-羥基丁酯、甲基丙烯酸4-羥基丁酯、丙烯酸2-羥基丁酯、甲基丙烯酸2-羥基丁酯、N-(2-羥乙基)丙烯醯胺、N-甲基-N-(2-羥乙基)丙烯醯胺、乙二醇單乙烯醚、二乙二醇單乙烯醚、四亞甲基二醇單乙烯醚等。(B)成分只要是該等單體中之任一種即可,亦可為兩種以上之混合物。Specific examples of the component (B) include 2-hydroxyethyl acrylate, 2-hydroxyethyl methacrylate, 2-hydroxypropyl acrylate, 2-hydroxypropyl methacrylate, 4-hydroxybutyl acrylate, 4-hydroxybutyl methacrylate, 2-hydroxybutyl acrylate, 2-hydroxybutyl methacrylate, N-(2-hydroxyethyl)acrylamide, N-methyl-N-(2-hydroxyethyl) Base) acrylamide, ethylene glycol monovinyl ether, diethylene glycol monovinyl ether, tetramethylene glycol monovinyl ether and the like. (B) As long as the component is any one of these monomers, it may be a mixture of two or more types.
就(A)成分之溶解性進一步改善之方面而言,較佳為丙烯酸2-羥基乙酯、甲基丙烯酸2-羥基乙酯、丙烯酸4-羥基丁酯、甲基丙烯酸4-羥基丁酯、乙二醇單乙烯醚、二乙二醇單乙烯醚、四亞甲基二醇單乙烯醚。In terms of further improving the solubility of component (A), 2-hydroxyethyl acrylate, 2-hydroxyethyl methacrylate, 4-hydroxybutyl acrylate, 4-hydroxybutyl methacrylate, Ethylene glycol monovinyl ether, diethylene glycol monovinyl ether, tetramethylene glycol monovinyl ether.
於本發明之隱形眼鏡用單體組合物中,當將所有單體成分之合計設為100質量%時,(B)成分之含有比率為5~45質量%。就改善(A)成分於隱形眼鏡用單體組合物中之溶解性之觀點而言,(B)成分之含有比率較佳為5~40質量%,更佳為7~38質量%,進而較佳為10~35質量%。若(B)成分之含有比率未達5質量%,則有本發明之組合物無法成為均勻透明液體之風險。另一方面,若多於45質量%則難以進一步提高(A)成分之溶解性。In the monomer composition for contact lenses of the present invention, when the total of all monomer components is 100% by mass, the content ratio of the component (B) is 5 to 45% by mass. From the viewpoint of improving the solubility of component (A) in the monomer composition for contact lenses, the content ratio of component (B) is preferably 5-40% by mass, more preferably 7-38% by mass, and more Preferably, it is 10 to 35% by mass. If the content ratio of the component (B) is less than 5% by mass, there is a risk that the composition of the present invention will not become a uniform transparent liquid. On the other hand, if it exceeds 45% by mass, it is difficult to further improve the solubility of the component (A).
<(C)成分:含矽氧烷基之伊康酸二酯單體> 本發明中之(C)成分為下述式(2)所表示之含矽氧烷基之伊康酸二酯單體。藉由含有特定量之(C)成分,能夠向使本發明之隱形眼鏡用單體組合物聚合而獲得之隱形眼鏡賦予優異之透氧性。<(C)Component: Iconic acid diester monomer containing siloxane group> The component (C) in the present invention is a siloxane group-containing itaconic acid diester monomer represented by the following formula (2). By containing the component (C) in a specific amount, it is possible to impart excellent oxygen permeability to contact lenses obtained by polymerizing the monomer composition for contact lenses of the present invention.
[化5] [化5]
式(2)之單體係藉由伊康酸單乙二醇酯與3-碘基丙基[三(三甲基矽烷氧基)]矽烷之酯化反應而獲得。伊康酸單乙二醇酯例如藉由WO2010/104000號公報中記載之方法而獲得。於該酯化反應中,副產出下述式(2')所表示之結構異構物。於本發明中,可將式(2)之單體與式(2')之單體之混合物用作(C)成分。即,於本發明中,「式(2)所表示之含矽氧烷基之伊康酸二酯單體」不僅包括單獨之式(2)之單體,還包括除式(2)之單體以外亦包含一部分式(2')之異構體者。The single system of formula (2) is obtained by the esterification reaction of monoethylene glycol itaconic acid and 3-iodopropyl[tris(trimethylsilyloxy)]silane. Iconate monoethylene glycol ester is obtained, for example, by the method described in WO2010/104000. In this esterification reaction, the structural isomer represented by the following formula (2') is produced by-product. In the present invention, a mixture of the monomer of formula (2) and the monomer of formula (2') can be used as the component (C). That is, in the present invention, "the siloxyalkyl-containing itaconic acid diester monomer represented by the formula (2)" includes not only the monomer of the formula (2) alone, but also the monomer of the formula (2) In addition to the isomers, a part of the isomers of formula (2') is also included.
[化6] [化6]
於本發明之隱形眼鏡用單體組合物中,當將所有單體成分之合計設為100質量%時,(C)成分之含有比率為7~35質量%。就向隱形眼鏡賦予透氧性之觀點而言,(C)成分之含有比率較佳為10~30質量%,更佳為10~25質量%,進而較佳為10~20質量%。若(C)成分之含有比率未達7質量%,則有所製造之隱形眼鏡用聚合物出現白濁之風險。另一方面,若多於35質量%,則有隱形眼鏡之機械強度降低,從而難以製造隱形眼鏡之風險。In the monomer composition for contact lenses of the present invention, when the total of all monomer components is 100% by mass, the content ratio of the component (C) is 7 to 35% by mass. From the viewpoint of imparting oxygen permeability to contact lenses, the content of the component (C) is preferably 10 to 30% by mass, more preferably 10 to 25% by mass, and still more preferably 10 to 20% by mass. If the content of (C) component is less than 7% by mass, there is a risk that the manufactured contact lens polymer will appear cloudy. On the other hand, if it is more than 35% by mass, there is a risk that the mechanical strength of the contact lens will decrease, making it difficult to manufacture the contact lens.
<(D)成分:含矽氧烷基之(甲基)丙烯酸酯> 本發明中之(D)成分係下述式(3)所表示之含矽氧烷基之(甲基)丙烯酸酯。藉由含有特定量之(D)成分,能夠向使本發明之隱形眼鏡用單體組合物聚合而獲得之隱形眼鏡賦予透氧性。<(D)Component: (meth)acrylate containing siloxane group> The component (D) in the present invention is a siloxane group-containing (meth)acrylate represented by the following formula (3). By containing the component (D) in a specific amount, it is possible to impart oxygen permeability to the contact lens obtained by polymerizing the monomer composition for contact lens of the present invention.
[化7] 式(3)中,R1 為氫原子或甲基。n表示二甲基矽氧烷部之重複數,為1~15。(D)成分可為重複數n不同之複數個化合物之混合物,於此情形時,n為數量平均分子量中之平均值,處於1~15之範圍,較佳為3~9之範圍。當n為3以上時,能夠賦予充分之透氧性,當n為9以下時,易獲得均勻地溶解之隱形眼鏡用單體組合物。[化7] In the formula (3), R 1 is a hydrogen atom or a methyl group. n represents the number of repetitions of the dimethylsiloxane moiety, and is 1-15. (D) The component may be a mixture of multiple compounds with different repeating numbers n. In this case, n is the average value of the number average molecular weight, in the range of 1-15, preferably 3-9. When n is 3 or more, sufficient oxygen permeability can be imparted, and when n is 9 or less, it is easy to obtain a uniformly dissolved monomer composition for contact lenses.
於本發明之隱形眼鏡用單體組合物中,當將所有單體成分之合計設為100質量%時,(D)成分之含有比率為7~55質量%。就向隱形眼鏡賦予透氧性之觀點而言,(D)成分之含有比率較佳為10~50質量%,更佳為13~45質量%,進而較佳為13~35質量%。若(D)成分之含有比率未達7質量%,則有所製造之隱形眼鏡用聚合物出現白濁之風險。另一方面,若多於55質量%,則有隱形眼鏡之機械強度降低,從而難以製造隱形眼鏡之風險。In the monomer composition for contact lenses of the present invention, when the total of all monomer components is 100% by mass, the content ratio of the component (D) is 7 to 55% by mass. From the viewpoint of imparting oxygen permeability to the contact lens, the content ratio of the component (D) is preferably 10 to 50% by mass, more preferably 13 to 45% by mass, and still more preferably 13 to 35% by mass. If the content of (D) component is less than 7% by mass, there is a risk that the manufactured contact lens polymer will appear cloudy. On the other hand, if it is more than 55% by mass, there is a risk that the mechanical strength of the contact lens will decrease, making it difficult to manufacture the contact lens.
<(E)成分:N-乙烯基吡咯啶酮> 本發明中之(E)成分為N-乙烯基吡咯啶酮。藉由含有特定量之(E)成分,能夠對於使本發明之隱形眼鏡用單體組合物聚合而獲得之隱形眼鏡賦予花粉及花粉蛋白之吸附抑制作用。 於本發明之隱形眼鏡用單體組合物中,當將所有單體成分之合計設為100質量%時,(E)成分之含有比率為0.5~35質量%。就隱形眼鏡之花粉及花粉蛋白之吸附抑制作用之觀點而言,(E)成分之含有比率較佳為0.5~30質量%,更佳為1~25質量%,進而較佳為1~10質量%,尤佳為1~5質量%。若(E)成分之含有比率未達0.5質量%,則有隱形眼鏡之花粉及花粉蛋白之吸附抑制作用變得不充分之風險。另一方面,若多於35質量%,則難以提高隱形眼鏡之花粉及花粉蛋白之吸附抑制作用。 進而,就隱形眼鏡之花粉及花粉蛋白吸附抑制作用之觀點而言,(A)成分相對於(E)成分之質量比(A)/(E)較佳為0.1~20,更佳為2~15,進而較佳為3~10,尤佳為5~10。<(E) Component: N-vinylpyrrolidone> The component (E) in the present invention is N-vinylpyrrolidone. By containing the component (E) in a specific amount, the contact lens obtained by polymerizing the monomer composition for contact lenses of the present invention can impart the adsorption inhibitory effect of pollen and pollen protein. In the monomer composition for contact lenses of the present invention, when the total of all monomer components is 100% by mass, the content ratio of the (E) component is 0.5 to 35% by mass. From the viewpoint of the pollen and pollen protein adsorption inhibitory effect of the contact lens, the content of the component (E) is preferably 0.5-30% by mass, more preferably 1-25% by mass, and still more preferably 1-10% by mass %, particularly preferably 1 to 5 mass%. If the content of (E) component is less than 0.5% by mass, there is a risk that the adsorption inhibitory effect of the pollen and pollen protein of the contact lens will become insufficient. On the other hand, if it is more than 35% by mass, it is difficult to improve the adsorption inhibitory effect of pollen and pollen protein of the contact lens. Furthermore, from the viewpoint of the pollen and pollen protein adsorption inhibitory effect of the contact lens, the mass ratio (A)/(E) of the component (A) to the component (E) is preferably 0.1-20, more preferably 2~ 15, more preferably 3-10, particularly preferably 5-10.
<(F)成分:光聚合起始劑> 本發明中之(F)成分為光聚合起始劑。藉由調配特定量之(F)成分,不僅能夠使本發明之隱形眼鏡用單體組合物聚合,從而製成透明性優異且良率優異之隱形眼鏡,亦能夠使(A)成分均勻地溶解於隱形眼鏡中並使其硬化,因此可製成花粉及花粉蛋白之吸附抑制作用優異之隱形眼鏡。 (F)成分並無特別限定,例如可列舉苯基雙(2,4,6-三甲基苯甲醯基)氧化膦、1-羥基環己基苯基酮、2-羥基-2-甲基-1-苯基-丙烷-1-酮、雙(2,6-二甲氧基苯甲醯基)-2,4,4-三甲基戊基氧化膦、雙(2,4,6-三甲基苯甲醯基)-苯基氧化膦、2,4,6-三甲基苄基二苯基氧化膦、2,4,6-三甲基苯甲醯基二苯基氧化膦、安息香甲酯、樟腦醌、及4-(N,N-二甲胺基)苯甲酸乙酯等。(F)成分可為一種,亦可為兩種以上之混合物。<Component (F): Photopolymerization initiator> The component (F) in the present invention is a photopolymerization initiator. By blending a specific amount of component (F), not only the monomer composition for contact lenses of the present invention can be polymerized to produce contact lenses with excellent transparency and yield, but also component (A) can be uniformly dissolved It is used in contact lenses and hardened, so it can be made into contact lenses with excellent pollen and pollen protein adsorption inhibitory effect. (F) The component is not particularly limited, and examples include phenylbis(2,4,6-trimethylbenzyl) phosphine oxide, 1-hydroxycyclohexyl phenyl ketone, and 2-hydroxy-2-methyl -1-Phenyl-propan-1-one, bis(2,6-dimethoxybenzyl)-2,4,4-trimethylpentylphosphine oxide, bis(2,4,6- Trimethylbenzyl)-phenylphosphine oxide, 2,4,6-trimethylbenzyldiphenylphosphine oxide, 2,4,6-trimethylbenzyldiphenylphosphine oxide, Benzoin methyl ester, camphorquinone, and ethyl 4-(N,N-dimethylamino)benzoate, etc. (F) The component may be one type or a mixture of two or more types.
於本發明之隱形眼鏡用單體組合物中,當將所有單體成分之合計設為100質量%時,(F)成分之含有比率為0.1~10質量%。就向隱形眼鏡之聚合性之觀點而言,較佳為0.5~5質量%,進而較佳為0.5~4質量%。若(F)成分之含有比率未達0.1質量%,則有聚合不完全,無法製作隱形眼鏡之風險。另一方面,當多於10質量%時,則有聚合不完全,無法製作隱形眼鏡之風險。In the monomer composition for contact lenses of the present invention, when the total of all monomer components is 100% by mass, the content ratio of the component (F) is 0.1-10% by mass. From the viewpoint of polymerizability to contact lenses, it is preferably 0.5 to 5% by mass, and more preferably 0.5 to 4% by mass. If the content of (F) component is less than 0.1% by mass, there is a risk of incomplete polymerization and failure to produce contact lenses. On the other hand, when it is more than 10% by mass, there is a risk of incomplete polymerization and failure to produce contact lenses.
<(G)成分:除(A)成分~(F)成分以外之單體等> 本發明之(G)成分為除(A)成分~(F)成分以外之單體等。(G)成分為任意成分,可以調整隱形眼鏡之機械強度或含水率等為目的來進行調配。 作為(G)成分,可例示具有醯胺基之單體、具有羧基之單體、具有酯基之單體。 作為具有醯胺基之單體,例如可列舉N-乙烯基哌啶-2-酮、N-乙烯基-ε-己內醯胺、N-乙烯基-3-甲基-2-己內醯胺、N,N-二甲基丙烯醯胺、N,N-二乙基丙烯醯胺、丙烯醯胺、N-異丙基丙烯醯胺、丙烯醯𠰌啉、N-乙烯基-N-甲基乙醯胺、N-乙烯基乙醯胺、N-乙烯基甲醯胺等。 作為具有羧基之單體,例如可列舉(甲基)丙烯酸、2-甲基丙烯醯氧基乙基琥珀酸等。 作為具有酯基之單體,例如可列舉(甲基)丙烯酸甲酯、(甲基)丙烯酸乙酯、(甲基)丙烯酸丁酯等(甲基)丙烯酸烷基酯、及甲氧基聚乙二醇甲基丙烯酸酯等。 (G)成分無論是該等單體中之任一種還是兩種以上之混合物,均可加以使用。 於本發明之隱形眼鏡用單體組合物含有(G)成分之情形時,當將所有單體成分之合計設為100質量%時,(G)成分之含有比率較佳為25質量%以下。<(G) component: monomers other than (A) component-(F) component, etc.> The (G) component of the present invention is a monomer other than the (A) component to (F) component. The component (G) is optional and can be formulated for the purpose of adjusting the mechanical strength and moisture content of the contact lens. As (G) component, the monomer which has an amide group, the monomer which has a carboxyl group, and the monomer which has an ester group can be illustrated. Examples of monomers having an amide group include N-vinylpiperidin-2-one, N-vinyl-ε-caprolactam, and N-vinyl-3-methyl-2-caprolactone. Amine, N,N-dimethylacrylamide, N,N-diethylacrylamide, acrylamide, N-isopropylacrylamide, acrylamide, N-vinyl-N-methyl Acetamide, N-vinylacetamide, N-vinylformamide, etc. Examples of the monomer having a carboxyl group include (meth)acrylic acid, 2-methacryloxyethyl succinic acid, and the like. Examples of monomers having ester groups include alkyl (meth)acrylates such as methyl (meth)acrylate, ethyl (meth)acrylate, and butyl (meth)acrylate, and methoxy polyethylene Diol methacrylate etc. The component (G) can be used regardless of whether it is any one of these monomers or a mixture of two or more of them. When the monomer composition for contact lenses of the present invention contains the (G) component, when the total of all the monomer components is 100% by mass, the content of the (G) component is preferably 25% by mass or less.
除上述(A)成分~(G)成分以外,本發明之隱形眼鏡用單體組合物亦可含有溶劑。溶劑並無特別限制,只要能夠改善各成分於組合物中之溶解性即可。 作為溶劑,例如可例示醇系溶劑或羧酸系溶劑。 作為醇系溶劑,例如可列舉乙醇、1-丙醇、2-丙醇、1-丁醇、2-丁醇、第三丁醇、1-戊醇、2-戊醇、第三胺基醇、1-己醇、1-辛醇、1-癸醇、1-十二烷醇等。 作為羧酸系溶劑,例如可列舉乙醇酸、乳酸、乙酸等。 溶劑無論是其中任一種還是兩種以上之混合物,均可加以使用。就隱形眼鏡聚合物之製造性之觀點而言,較佳為乙醇、1-丙醇、2-丙醇、1-丁醇、1-戊醇、2-戊醇、1-己醇、1-辛醇、1-癸醇。 於本發明之隱形眼鏡用單體組合物含有溶劑之情形時,當將所有單體成分之合計設為100質量%時,溶劑之含有比率較佳為25質量%以下。In addition to the above-mentioned (A) component to (G) component, the monomer composition for contact lenses of the present invention may contain a solvent. The solvent is not particularly limited, as long as it can improve the solubility of each component in the composition. As the solvent, for example, an alcohol-based solvent or a carboxylic acid-based solvent can be exemplified. Examples of alcohol solvents include ethanol, 1-propanol, 2-propanol, 1-butanol, 2-butanol, tertiary butanol, 1-pentanol, 2-pentanol, and tertiary amino alcohol. , 1-hexanol, 1-octanol, 1-decanol, 1-dodecanol, etc. Examples of carboxylic acid solvents include glycolic acid, lactic acid, acetic acid, and the like. Either one of these solvents or a mixture of two or more of them can be used. From the viewpoint of the manufacturability of the contact lens polymer, ethanol, 1-propanol, 2-propanol, 1-butanol, 1-pentanol, 2-pentanol, 1-hexanol, 1- Octanol, 1-decanol. When the monomer composition for contact lenses of the present invention contains a solvent, when the total of all monomer components is 100% by mass, the content of the solvent is preferably 25% by mass or less.
除上述(A)成分~(G)成分以外,本發明之隱形眼鏡用單體組合物亦可含有交聯劑。交聯劑通常具有2個以上之聚合性不飽和基,可使用公知之交聯劑。作為交聯劑,例如除矽酮二甲基丙烯酸酯以外,亦可列舉乙二醇二乙烯醚、二乙二醇二乙烯醚、三乙二醇二乙烯醚、乙二醇二甲基丙烯酸酯、二乙二醇二甲基丙烯酸酯、三乙二醇二甲基丙烯酸酯、四乙二醇二甲基丙烯酸酯、亞甲雙丙烯醯胺、甲基丙烯酸烯丙酯、甲基丙烯酸(2-烯丙氧基)乙酯、丙烯酸2-(2-乙烯氧基乙氧基)乙酯、及甲基丙烯酸2-(2-乙烯氧基乙氧基)乙酯等。交聯劑無論是其中任一種還是兩種以上之混合物,均可加以使用。於本發明之隱形眼鏡用單體組合物中,當將所有單體成分之合計設為100質量%時,交聯劑之含有比率較佳為0.1~10質量%。In addition to the above-mentioned (A) component to (G) component, the monomer composition for contact lenses of the present invention may contain a crosslinking agent. The crosslinking agent usually has two or more polymerizable unsaturated groups, and a known crosslinking agent can be used. As the crosslinking agent, for example, in addition to silicone dimethacrylate, ethylene glycol divinyl ether, diethylene glycol divinyl ether, triethylene glycol divinyl ether, and ethylene glycol dimethacrylate can also be cited. , Diethylene glycol dimethacrylate, triethylene glycol dimethacrylate, tetraethylene glycol dimethacrylate, methylene bisacrylamide, allyl methacrylate, methacrylic acid (2 -Allyloxy) ethyl, 2-(2-vinyloxyethoxy) ethyl acrylate, 2-(2-vinyloxyethoxy) ethyl methacrylate, etc. The crosslinking agent can be used regardless of whether it is any one of them or a mixture of two or more. In the monomer composition for contact lenses of the present invention, when the total of all monomer components is 100% by mass, the content ratio of the crosslinking agent is preferably 0.1-10% by mass.
除上述(A)成分~(G)成分以外,本發明之隱形眼鏡用單體組合物亦可於不阻礙本發明之目的之範圍內,含有紫外線吸收劑、著色劑等添加劑。In addition to the above-mentioned (A) component to (G) component, the monomer composition for contact lenses of the present invention may contain additives such as ultraviolet absorbers and colorants within a range that does not hinder the purpose of the present invention.
[隱形眼鏡用聚合物、隱形眼鏡] 本發明之隱形眼鏡用聚合物係藉由使上述隱形眼鏡用單體組合物聚合而獲得。具體而言,使本發明之隱形眼鏡用單體組合物混合並均勻地溶解,將其分注至隱形眼鏡用模具,藉由於特定時間內照射可見光或UV(Ultraviolet,紫外線)光來進行聚合,從而可獲得隱形眼鏡用聚合物。[Polymers for contact lenses, contact lenses] The polymer for contact lenses of the present invention is obtained by polymerizing the above-mentioned monomer composition for contact lenses. Specifically, the monomer composition for contact lenses of the present invention is mixed and uniformly dissolved, dispensed into a mold for contact lenses, and polymerized by irradiating visible light or UV (Ultraviolet) light within a specific period of time. Thus, a polymer for contact lenses can be obtained.
聚合反應可於大氣中進行,但為了提高單體之聚合率,亦可於氮氣或氬氣等惰性氣體氛圍中進行。當於惰性氣體氛圍中進行聚合時,較理想為將聚合系統中之壓力設為1 kgf/cm2 以下。 於聚合後,可利用公知之方法使其自模具脫模,並於乾燥狀態下取出隱形眼鏡用聚合物。又,亦可將隱形眼鏡用聚合物與模具一同浸漬於溶劑(例如水、甲醇、乙醇、1-丙醇、2-丙醇、及該等之混合溶液)中,使隱形眼鏡用聚合物膨潤,從而使其脫模。進而,將其反覆浸漬於該等溶劑等來進行洗淨,去除各成分之殘渣及殘留物、副產物等,從而可製成隱形眼鏡。The polymerization reaction can be carried out in the atmosphere, but in order to increase the polymerization rate of the monomers, it can also be carried out in an inert gas atmosphere such as nitrogen or argon. When performing polymerization in an inert gas atmosphere, it is preferable to set the pressure in the polymerization system to 1 kgf/cm 2 or less. After the polymerization, a known method can be used to release the mold from the mold, and the polymer for contact lenses can be taken out in a dry state. In addition, the polymer for contact lenses and the mold can be immersed in a solvent (for example, water, methanol, ethanol, 1-propanol, 2-propanol, and mixed solutions of these) to swell the polymer for contact lenses , So as to make it demould. Furthermore, it is repeatedly immersed in these solvents etc. for washing, and the residues, residues, by-products, etc. of each component are removed, and a contact lens can be manufactured.
作為洗淨時所使用之溶劑,可列舉水、甲醇、乙醇、1-丙醇、2-丙醇、該等之混合物等。關於洗淨,例如可於10℃~40℃之溫度下使聚合物於醇系溶劑中浸漬10分鐘~10小時。又,亦可於在醇系溶劑中洗淨之後,使其於醇濃度設為20~50質量%之水溶液中浸漬10分鐘~10小時來進行洗淨。 用於洗淨用之溶劑可使用任意溶劑,只要具備用於醫藥、準藥品、醫療設備之品質即可。As the solvent used for washing, water, methanol, ethanol, 1-propanol, 2-propanol, mixtures of these, and the like can be mentioned. For washing, for example, the polymer can be immersed in an alcohol solvent at a temperature of 10°C to 40°C for 10 minutes to 10 hours. Moreover, after washing in an alcohol-based solvent, it may be immersed in an aqueous solution having an alcohol concentration of 20 to 50% by mass for 10 minutes to 10 hours for washing. Any solvent can be used for the cleaning solvent, as long as it has the quality for medicine, quasi-drug, and medical equipment.
本發明之隱形眼鏡係使上述隱形眼鏡用聚合物進行水合而獲得。具體而言,將洗淨後之隱形眼鏡聚合物浸漬於生理鹽水,以達到特定含水率之方式使其進行水合,藉此獲得本發明之隱形眼鏡。生理鹽水可使用包含硼酸緩衝劑之生理鹽水、或包含磷酸緩衝劑之生理鹽水。The contact lens of the present invention is obtained by hydrating the above-mentioned polymer for contact lens. Specifically, the cleaned contact lens polymer is immersed in physiological saline to hydrate it in a manner to achieve a specific moisture content, thereby obtaining the contact lens of the present invention. As the physiological saline, physiological saline containing a boric acid buffer or physiological saline containing a phosphate buffer can be used.
本發明之隱形眼鏡係藉由上述特定組成之隱形眼鏡用單體組合物而獲得,能夠抑制花粉及花粉蛋白吸附於隱形眼鏡表面。即,本發明之隱形眼鏡能夠較佳地用於抑制花粉及/或花粉蛋白之吸附。 [實施例]The contact lens of the present invention is obtained by the monomer composition for contact lens with the above-mentioned specific composition, which can inhibit the adsorption of pollen and pollen protein on the surface of the contact lens. That is, the contact lens of the present invention can be preferably used to inhibit the adsorption of pollen and/or pollen protein. [Example]
以下,藉由實施例及比較例,更詳細地對本發明進行說明,但本發明並不限定於該等實施例及比較例。 以下,展示本實施例及比較例中使用之化合物。Hereinafter, the present invention will be described in more detail with examples and comparative examples, but the present invention is not limited to these examples and comparative examples. Hereinafter, the compounds used in the present examples and comparative examples are shown.
(A)成分 MPC:2-甲基丙烯醯氧乙基磷酸膽鹼(A) Ingredient MPC: 2-Methacryloxyethyl Phosphate Choline
(B)成分 HEA:丙烯酸羥基乙酯 HEAA:羥乙基丙烯醯胺 HEMA:甲基丙烯酸羥基乙酯 HPMA:甲基丙烯酸羥基丙酯 HBMA:甲基丙烯酸羥基丁酯 EGMV:乙二醇單乙烯醚 DGMV:二乙二醇單乙烯醚 TGMV:四乙二醇單乙烯醚(B) Ingredients HEA: Hydroxyethyl acrylate HEAA: Hydroxyethyl acrylamide HEMA: Hydroxyethyl methacrylate HPMA: Hydroxypropyl methacrylate HBMA: hydroxybutyl methacrylate EGMV: Ethylene glycol monovinyl ether DGMV: Diethylene glycol monovinyl ether TGMV: Tetraethylene glycol monovinyl ether
(C)成分 ETS:伊康酸單乙二醇酯與3-碘基丙基[三(三甲基矽烷氧基)]矽烷之酯化反應物即式(2)之化合物 (D)成分 MCR-M07:式(3)之化合物[R1:甲基、n:6、數量平均分子量:600-800](C) Ingredients ETS: The esterification reactant of monoethylene glycol itaconic acid and 3-iodopropyl [tris(trimethylsilyloxy)] silane is the compound of formula (2) (D) Ingredients MCR-M07: compound of formula (3) [R1: methyl, n: 6, number average molecular weight: 600-800]
(E)成分 NVP:N-乙烯基吡咯啶酮 (F)成分 I-819:苯基雙(2,4,6-三甲基苯甲醯基)氧化膦(E) Ingredients NVP: N-vinylpyrrolidone (F) Ingredients I-819: Phenylbis(2,4,6-trimethylbenzyl) phosphine oxide
(G)成分 MMA:甲基丙烯酸甲酯 其他成分 HeOH:1-己醇 TEGDMA:四乙二醇二甲基丙烯酸酯 TEGDV:三乙二醇二乙烯醚(G) Ingredients MMA: methyl methacrylate Other ingredients HeOH: 1-hexanol TEGDMA: Tetraethylene glycol dimethacrylate TEGDV: Triethylene glycol divinyl ether
對於實施例及比較例中製作之隱形眼鏡用單體組合物、隱形眼鏡用聚合物、及隱形眼鏡,利用以下方法進行評估。The monomer composition for contact lenses, the polymer for contact lenses, and the contact lenses produced in the examples and comparative examples were evaluated by the following methods.
<組合物之均勻性及溶解性> 將組合物放入無色透明之容器,藉由目視並利用以下基準來進行評估。 〇:均勻且透明 ×:不均勻,存在白濁或沈澱物等<The uniformity and solubility of the composition> The composition was put into a colorless and transparent container, and the evaluation was performed by visual inspection using the following criteria. 〇: Uniform and transparent ×: Inhomogeneous, with white turbidity or sediment, etc.
<聚合物之形態> 藉由目視並利用以下基準來對隱形眼鏡用聚合物之形態進行評估。 〇:呈固態 ×:呈液態(包含黏稠性液體)<Form of polymer> The morphology of the polymer for contact lenses was evaluated visually and using the following criteria. 〇: Solid ×: Liquid (including viscous liquid)
<透氧性> 關於隱形眼鏡之透氧性,以如下方式測定透氧係數來進行評估。 使用厚度不同之樣品,根據ISO 18369-4中記載之極譜法之測定方法來測定透氧係數。測定中使用了雷德爾發展公司(Rehder Development Company)之O2 Permeometer Model 201T。以鏡片之厚度為x軸,以藉由測定所求出之t/Dk值為y軸進行繪圖,將回歸線之斜率之倒數設為透氧係數。透氧係數愈大透氧性愈高,將透氧係數為60以上之情形判定為合格基準以上,將透氧係數為80以上之情形判定為良好。<Oxygen Permeability> The oxygen permeability of contact lenses was evaluated by measuring the oxygen permeability coefficient as follows. Use samples with different thicknesses to determine the oxygen permeability coefficient according to the polarographic method described in ISO 18369-4. The O 2 Permeometer Model 201T of Rehder Development Company (Rehder Development Company) was used in the measurement. The thickness of the lens is taken as the x-axis, and the t/Dk value obtained by the measurement is plotted on the y-axis, and the reciprocal of the slope of the regression line is set as the oxygen permeability coefficient. The larger the oxygen permeability coefficient, the higher the oxygen permeability. The case where the oxygen permeability coefficient is 60 or more is judged as the pass criterion or higher, and the case where the oxygen permeability coefficient is 80 or more is judged as good.
<花粉吸附性試驗、花粉蛋白吸附性試驗> 於以下花粉吸附性試驗及花粉蛋白吸附性試驗中,使用了磷酸緩衝液(以下,稱為「PBS」)。PBS(組成:氯化鉀0.02 w/v%、磷酸二氫鉀0.02 w/v%、氯化鈉0.8 w/v%、磷酸氫二鈉0.115 w/v%)係使用西格瑪奧德里奇(Sigma-Aldrich)之製品。<Pollen adsorption test, pollen protein adsorption test> In the following pollen adsorption test and pollen protein adsorption test, a phosphate buffer solution (hereinafter referred to as "PBS") was used. PBS (composition: potassium chloride 0.02 w/v%, potassium dihydrogen phosphate 0.02 w/v%, sodium chloride 0.8 w/v%, disodium hydrogen phosphate 0.115 w/v%) is based on Sigma-Aldrich (Sigma -Aldrich) products.
(花粉吸附性試驗) 按照以下順序,使用各實施例及各比較例之隱形眼鏡實施花粉吸附性試驗。 (1)取出一片隱形眼鏡,利用10 mL之PBS進行沖洗,進而於2 mL之PBS中浸漬一整晚。 (2)使用日本柳杉花粉(Biostir製造)及PBS,以日本柳杉花粉濃度成為3 mg/mL之方式製備溶液(以下,稱為「花粉溶液」)。 (3)新準備24孔板,於其中放入1.5 mL之花粉溶液,進而使(1)中準備之隱形眼鏡浸漬於該花粉溶液中。之後,為了使花粉充分地吸附於隱形眼鏡之兩面,每過約1小時將隱形眼鏡翻轉一次。 (4)於自浸漬開始5小時後取出軟性隱形眼鏡,藉由10 mL之PBS充分地將其洗淨。 (5)準備新的24孔板,於其中放入洗淨後之隱形眼鏡及2 mL之PBS,並使其振盪5分鐘。 (6)使用顯微鏡,對吸附於隱形眼鏡之花粉進行測量。 再者,關於花粉吸附性試驗,使用以下基準來判斷隱形眼鏡之花粉吸附抑制效果。 以比較例1-5為基準,使用下式計算出花粉吸附抑制率,來判斷有無花粉吸附抑制效果。 花粉吸附抑制率={1-[(各實施例或各比較例之花粉吸附量)/(比較例1-5之花粉吸附量)]}×100 《判斷基準》 花粉吸附抑制率為70%以上:花粉吸附抑制效果極其優異 花粉吸附抑制率為50%以上且未達70%:花粉吸附抑制效果優異 花粉吸附抑制率為30%以上且未達50%:具有花粉吸附抑制效果 花粉吸附抑制率未達30%:不具備花粉吸附抑制效果(Pollen adsorption test) In the following order, a pollen adsorption test was performed using the contact lenses of each example and each comparative example. (1) Take out a piece of contact lens, rinse it with 10 mL of PBS, and then soak it in 2 mL of PBS overnight. (2) Using Japanese cedar pollen (manufactured by Biostir) and PBS, a solution (hereinafter referred to as "pollen solution") was prepared so that the concentration of Japanese cedar pollen was 3 mg/mL. (3) Prepare a new 24-well plate, put 1.5 mL of pollen solution in it, and then immerse the contact lens prepared in (1) in the pollen solution. After that, in order to fully absorb the pollen on both sides of the contact lens, the contact lens was turned over every about 1 hour. (4) Take out the soft contact lens 5 hours after the start of immersion, and wash it thoroughly with 10 mL of PBS. (5) Prepare a new 24-well plate, put the washed contact lenses and 2 mL of PBS into it, and shake it for 5 minutes. (6) Use a microscope to measure the pollen adsorbed on the contact lens. In addition, regarding the pollen adsorption test, the following criteria were used to determine the pollen adsorption inhibitory effect of contact lenses. Based on Comparative Example 1-5, the pollen adsorption inhibition rate was calculated using the following formula to determine whether there is a pollen adsorption inhibition effect. Pollen adsorption inhibition rate={1-[(pollen adsorption amount of each example or each comparative example)/(pollen adsorption amount of comparative example 1-5)]}×100 "Criteria of Judgment" Pollen adsorption inhibition rate is more than 70%: pollen adsorption inhibition effect is extremely excellent Pollen adsorption inhibition rate is more than 50% and less than 70%: excellent pollen adsorption inhibition effect Pollen adsorption inhibition rate is more than 30% and less than 50%: it has pollen adsorption inhibition effect Pollen adsorption inhibition rate is less than 30%: no pollen adsorption inhibition effect
(花粉蛋白吸附性試驗) 按照以下順序,對各實施例及各比較例中之隱形眼鏡實施花粉蛋白之吸附性試驗。 (1)將花粉吸附性試驗後之各實施例及各比較例之隱形眼鏡移至新的24孔板,放入2 mL之PBS並靜置30分鐘。 (2)此外,利用PBS將過氧化酶標記抗Cryj1抗體稀釋至1000倍。 (3)於樣品袋中裝入1 mL之(2)中製備之溶液,進而,使(1)中準備之隱形眼鏡浸漬於其中,並於室溫下振盪3小時。 (4)於靜置後,取出浸漬後之隱形眼鏡,利用20 mL之PBS充分地進行沖洗,並將其放入新的24孔板中。 (5)添加2 mL之PBS,進行10分鐘之洗淨。為了充分地將其洗淨,再次實施該洗淨操作。 (6)使用DAB Substrate Kit(SK-4100、Vector製造),進行DAB(Diaminobenzidine,二胺基聯苯胺)顯色溶液之製備,並向24孔板中添加1.2 mL。 (7)將於(5)中洗淨之隱形眼鏡放入(6)之24孔板,使其至少反應2小時。之後,利用純化水洗淨,測定450 nm下之吸光度,從而測量吸附於隱形眼鏡之花粉蛋白量(由於所吸附之花粉蛋白量與吸光度為依存關係,因此判斷吸光度較低者所吸附之花粉蛋白量較少)。(Pollen protein adsorption test) In accordance with the following sequence, the pollen protein adsorption test was performed on the contact lenses in each example and each comparative example. (1) Move the contact lenses of each example and each comparative example after the pollen adsorption test to a new 24-well plate, put 2 mL of PBS and let it stand for 30 minutes. (2) In addition, the peroxidase-labeled anti-Cryj1 antibody was diluted 1000 times with PBS. (3) Put 1 mL of the solution prepared in (2) into the sample bag, and then immerse the contact lens prepared in (1) in it, and shake at room temperature for 3 hours. (4) After standing still, take out the immersed contact lenses, rinse them thoroughly with 20 mL of PBS, and put them in a new 24-well plate. (5) Add 2 mL of PBS and wash for 10 minutes. In order to wash it sufficiently, this washing operation is performed again. (6) Using DAB Substrate Kit (manufactured by SK-4100, Vector), prepare DAB (Diaminobenzidine) coloring solution, and add 1.2 mL to the 24-well plate. (7) Put the cleaned contact lens in (5) into the 24-well plate of (6) and let it react for at least 2 hours. After that, wash with purified water and measure the absorbance at 450 nm to measure the amount of pollen protein adsorbed on the contact lens (because the amount of pollen protein adsorbed is dependent on the absorbance, the pollen protein adsorbed by the lower absorbance is judged Less amount).
[實施例1-1] 將8.6 g之MPC、8.7 g之HBMA、17.4 g之EGMV、13.1 g之ETS、30.5 g之MCR-M07、8.7 g之NVP、13.0 g之MMA、1.0 g之TEGDMA、2.5 g之TEGDV及10.0 g之HeOH混合,並使其等均勻地溶解,從而獲得組合物。對該組合物進行上述組合物之均勻性及溶解性之評估。將各成分之含有比率及評估結果示於表1。 向上述組合物添加1.0 g之I-819以製備隱形眼鏡用單體組合物,使該組合物流入將厚度0.1 mm之聚對苯二甲酸乙二酯片作為間隔件夾在2片聚丙烯板之間而成之25 mm×70 mm×0.2 mm之槽內,並將其置於UV照射裝置(CCS股份有限公司製造)內。於UV照射裝置內照射405 nm、1.5 mW/cm2 之UV光30分鐘,使組合物聚合,從而獲得隱形眼鏡用聚合物。將該聚合物自槽中取出,進行上述評估。將聚合條件及評估結果示於表1。[Example 1-1] 8.6 g of MPC, 8.7 g of HBMA, 17.4 g of EGMV, 13.1 g of ETS, 30.5 g of MCR-M07, 8.7 g of NVP, 13.0 g of MMA, 1.0 g of TEGDMA, 2.5 g of TEGDV and 10.0 g of HeOH were mixed and dissolved uniformly to obtain a composition. The composition was evaluated for the homogeneity and solubility of the above-mentioned composition. Table 1 shows the content ratio of each component and the evaluation result. 1.0 g of I-819 was added to the above composition to prepare a monomer composition for contact lenses, and the composition was allowed to flow. A polyethylene terephthalate sheet with a thickness of 0.1 mm was sandwiched between two polypropylene plates as a spacer. Place it in the UV irradiation device (manufactured by CCS Co., Ltd.). In a UV irradiation device, 405 nm, 1.5 mW/cm 2 UV light was irradiated for 30 minutes to polymerize the composition to obtain a polymer for contact lenses. The polymer was taken out of the tank, and the above evaluation was performed. Table 1 shows the polymerization conditions and evaluation results.
使上述聚合物於40 g之2-丙醇中浸漬4小時後,於50 g之離子交換水中浸漬4小時來去除未反應物等,從而將其純化。將純化後之聚合物浸漬於ISO18369-3中記載之生理鹽水中,使其膨潤(水合),從而製備水合物。以成為適用於各評估之形狀之方式對該水合物進行加工,從而製成評估用隱形眼鏡。將各評估之結果示於表1。After immersing the above polymer in 40 g of 2-propanol for 4 hours, it was immersed in 50 g of ion-exchanged water for 4 hours to remove unreacted materials and the like, thereby purifying it. The purified polymer is immersed in the physiological saline described in ISO18369-3 and swelled (hydrated) to prepare a hydrate. The hydrate is processed in a shape suitable for each evaluation to prepare contact lenses for evaluation. The results of each evaluation are shown in Table 1.
[實施例1-2~實施例1-8、比較例1-1~比較例1-5] 根據表1中記載之成分、分量,以與實施例1-1同樣之方式進行操作,從而製成實施例1-2~實施例1-8及比較例1-1~比較例1-5之評估用隱形眼鏡。將各評估之結果示於表1。[Example 1-2 to Example 1-8, Comparative Example 1-1 to Comparative Example 1-5] According to the ingredients and amounts described in Table 1, the operation was carried out in the same manner as in Example 1-1 to prepare Examples 1-2 to Example 1-8 and Comparative Example 1-1 to Comparative Example 1-5. Contact lenses for evaluation. The results of each evaluation are shown in Table 1.
[表1]
[表2]
[實施例2-1] 使用實施例1-1之隱形眼鏡,並將作為試驗對象之花粉自日本柳杉花粉變更為表3所記載之扁柏花粉,來實施花粉吸附性試驗及花粉蛋白吸附性試驗。將其結果示於表3。[Example 2-1] Using the contact lens of Example 1-1, the pollen as the test object was changed from Japanese cedar pollen to the cypress pollen described in Table 3, and the pollen adsorption test and the pollen protein adsorption test were carried out. The results are shown in Table 3.
[實施例2-2~實施例2-8] 使用表3中記載之實施例之隱形眼鏡及各種花粉來實施花粉吸附性試驗及花粉蛋白吸附性試驗。將結果示於表3。[Example 2-2 to Example 2-8] Using the contact lenses of the examples described in Table 3 and various pollens, the pollen adsorption test and the pollen protein adsorption test were carried out. The results are shown in Table 3.
[表3]
於實施例1-1~實施例1-8之隱形眼鏡中,花粉吸附抑制率為84%~99%,於比較例1-1之隱形眼鏡中,花粉吸附抑制率為13%,實施例展現出極其優異之花粉吸附抑制效果。於比較例1-2~比較例1-4之隱形眼鏡中,雖然展現出花粉吸附抑制效果,但聚合物之形態較差,並不適合作為隱形眼鏡。 同樣,可知各實施例之隱形眼鏡之花粉蛋白吸附抑制效果與比較例相比更為優異。 關於該等花粉吸附抑制效果及花粉蛋白吸附抑制效果,可知變更了花粉種類之實施例2-1~實施例2-8之隱形眼鏡亦展現出優異之效果。 [產業上之可利用性]In the contact lenses of Examples 1-1 to 1-8, the pollen adsorption inhibition rate was 84% to 99%. In the contact lenses of Comparative Example 1-1, the pollen adsorption inhibition rate was 13%. The examples show It has an excellent pollen adsorption inhibitory effect. In the contact lenses of Comparative Example 1-2 to Comparative Example 1-4, although the pollen adsorption inhibitory effect was exhibited, the polymer had a poor morphology and was not suitable as a contact lens. Similarly, it can be seen that the pollen protein adsorption inhibitory effect of the contact lenses of each example is more excellent than that of the comparative example. Regarding these pollen adsorption inhibitory effects and pollen protein adsorption inhibitory effects, it can be seen that the contact lenses of Examples 2-1 to 2-8 in which the types of pollen are changed also exhibit excellent effects. [Industrial availability]
藉由使用本發明之隱形眼鏡,能夠抑制花粉及花粉蛋白吸附於隱形眼鏡表面,因此能夠緩和、減輕花粉症之諸多症狀,進而使得不適感減輕,因此能夠成為配戴感優異之隱形眼鏡。By using the contact lens of the present invention, the adsorption of pollen and pollen protein on the surface of the contact lens can be suppressed, so that many symptoms of hay fever can be alleviated and reduced, and discomfort can be reduced. Therefore, it can be a contact lens with excellent wearing feeling.
Claims (4)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2020049788 | 2020-03-19 | ||
JP2020-049788 | 2020-03-19 |
Publications (1)
Publication Number | Publication Date |
---|---|
TW202140584A true TW202140584A (en) | 2021-11-01 |
Family
ID=77770872
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW110109153A TW202140584A (en) | 2020-03-19 | 2021-03-15 | Monomer composition for contact lens and polymer for contact lens |
Country Status (3)
Country | Link |
---|---|
JP (1) | JPWO2021187394A1 (en) |
TW (1) | TW202140584A (en) |
WO (1) | WO2021187394A1 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP4296761A1 (en) * | 2021-04-21 | 2023-12-27 | NOF Corporation | Monomer composition for contact lenses, polymer of said monomer composition, contact lens, and method for producing said contact lens |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2010104000A1 (en) * | 2009-03-09 | 2010-09-16 | 日油株式会社 | Silicone monomer |
JP5637673B2 (en) * | 2009-09-30 | 2014-12-10 | ロート製薬株式会社 | Ophthalmic composition |
KR102104222B1 (en) * | 2010-07-30 | 2020-04-24 | 알콘 인코포레이티드 | Silicone hydrogel lenses with water-rich surfaces |
KR20140104174A (en) * | 2013-02-20 | 2014-08-28 | (주)엔보이비젼 | Composition for preventing protein adsorption and application thereof |
JP5452756B1 (en) * | 2013-07-02 | 2014-03-26 | Hoya株式会社 | Method for producing silicone-containing copolymer molded article having hydrophilic surface and silicone hydrogel contact lens having hydrophilic surface |
JP6807011B2 (en) * | 2016-02-15 | 2021-01-06 | 日油株式会社 | Contact lenses with a phosphorylcholine group-containing hydrophilic polymer on the surface |
JP7014185B2 (en) * | 2017-01-17 | 2022-02-01 | 日油株式会社 | Monomer composition for contact lenses, polymers for contact lenses and methods for producing them, and contact lenses and methods for producing them. |
JP6907845B2 (en) * | 2017-09-13 | 2021-07-21 | 日油株式会社 | Monomer composition for contact lenses, polymers for contact lenses and methods for producing them, and contact lenses and methods for producing them. |
-
2021
- 2021-03-15 WO PCT/JP2021/010269 patent/WO2021187394A1/en active Application Filing
- 2021-03-15 TW TW110109153A patent/TW202140584A/en unknown
- 2021-03-15 JP JP2022508334A patent/JPWO2021187394A1/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
WO2021187394A1 (en) | 2021-09-23 |
JPWO2021187394A1 (en) | 2021-09-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US11872327B2 (en) | Medical device | |
KR102452750B1 (en) | Triblock prepolymers and their use in silicone hydrogels | |
CN103502847B (en) | Medical devices having homogeneous charge density and methods for making same | |
TWI753090B (en) | Monomer composition for contact lens, polymer for contact lens and method for preparing the same, as well as contact lens and method for producing the same | |
JP6807011B2 (en) | Contact lenses with a phosphorylcholine group-containing hydrophilic polymer on the surface | |
TW201815855A (en) | Silicone hydrogels comprising polyamides | |
JP6338263B2 (en) | Low hydrous soft device and manufacturing method thereof | |
WO2006057823A1 (en) | Ophthalmic compositions comprising polyether substituted polymers | |
JP2010532417A (en) | Soluble silicone prepolymer | |
EP3356433B1 (en) | New polymer materials for contact lens applications | |
CN108690211A (en) | Ophthalmic lens and method for producing same | |
TWI813875B (en) | Monomer composition for contact lens, polymer for contact lens and production method thereof, and contact lens and production method thereof | |
TWI614287B (en) | Macroinitiator containing hydrophobic segment | |
TW202140584A (en) | Monomer composition for contact lens and polymer for contact lens | |
CN109814276A (en) | Eye lens and its manufacturing method | |
JP2001048939A (en) | Polymer and ophthalmic lens using the same | |
JP6944124B2 (en) | Ophthalmic agent | |
TWI826534B (en) | Monomer composition for contact lens, polymer thereof, contact lens and method of producing the same | |
JP7446496B1 (en) | Contact lenses and silicone hydrogel contact lenses | |
WO2024135813A1 (en) | Curable composition, silicone hydrogel, method for producing silicone hydrogel, and method for producing contact lens | |
TW202423997A (en) | Monomer composition for contact lens, polymer for contact lens, and contact lens | |
JP2926804B2 (en) | Soft contact lens | |
JP7004205B2 (en) | Treatment liquid for contact lenses | |
TW202432642A (en) | Curable composition, polysilicone hydrogel, method for producing polysilicone hydrogel, and method for producing contact lens | |
TW202407388A (en) | Soft contact lens having coating layer |